These facts are updated till 18 March 2024, and are based on Volza's India Import dataIndia Import data of Cefixime mg sourced from 70 countries export import shipments with names of buyers, suppliers, top Decision maker's contact information like Direct, phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
38220090 | REAGENT >> C-919 CEFIXIME IMPURITY E 50 MG[LAB REAGENT FOR RUO] - | Canada | India | 1 | |||
38220090 | CEFIXIME >> CEFIXIME 500 MG | United States | India | 1 | |||
29335990 | PHARMACEUTICAL >> USP-1097658-CEFIXIME 500 MG PHARMACEUTICAL REFERENCE STANDARD - 1NOS | United States | India | 500 | |||
30049099 | SUSPENSION >> ORAL SUSPENSION RE-IMPORT PHARMACEUTICAL ITEMS - 102 CTN OF CESH-100 CEFIXIM FOR ORAL SUSPENSION USP 100 MG- 5 ML | India | India | 10175 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | 60 More Columns Available | ||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME 500 MG - 1NOS | United States | India | 500 | |||
29339900 | LABARATORY >> CEFIXIME 500 MG -125110-14-7 REFRENCE : 1097658 REFERENCE STANDARD MATERIAL-FOR LABARATORY USE ONLY | United States | India | 1 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS - | United States | India | 500 | |||
38220090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - USP REFERENCE STANDARDS - FOR LABORATORY USE | United States | India | 1 | |||
30041090 | PRICE >> CEFIXIME TRIHYDRATE POWDER FOR ORAL SUSPENSION 100-5 MG-ML OROKEN CHILDREN QTY: 10 NOS , PRICE: USD 25 EACH | France | India | 0.30 | |||
30043200 | CEFIXIME >> SUPRAX CEFIXIME SUPRAX CEFIXIME 200 MG-5ML P-NO.:27437-0206-02 | United States | India | 3 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> CEFIXIME 500 MG | United States | India | 500 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 2 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
30049099 | TABLETS >> CEFIXIME FINE GRANULES 50 MG CEFSPAN -QTY-480 TABLETS-FOR TEST OR ANALYSIS PURPOSE ONLY- PERISHABLE CARGO | China | India | 0.10 | |||
30049099 | TABLETS >> CEFIXIME TABLETS CEFIXIME TABLETS 400 MG SUPRAX PACK -10 S , QTY-20 BLISTER AS PER TEST LIC.NO.TL-BDZ-21-000223 DT:22-09-2021 | Canada | India | 200 | |||
29419090 | PRICE >> CEFIXIME QTY:1 X 500 MG , PRICE:USD-245.00 FOC HS 29419090 | China | India | 0.01 | |||
30049099 | AURO-CEFIXIME TABLETS, 400 MG 400 MG 7 BLISTER 7'S BLISTER LOT# OXMTS21019A | Canada | India | 7 | |||
30049099 | CEFIXIME POWDER FOR ORAL SUSPENSION 100 MG / 5 ML, 12 BOXES OF 1 BOTTLE NCV | Austria | India | 12 | |||
30049099 | FREE SAMPLE - CEFIXIME ORAL SUSPENSION 100 MG/5ML OROKEN 100MG/5ML 100/5 MG/ML - NO COMMERCIAL VALUE | Senegal | India | 50 | |||
30039099 | CEFIXIME 100 MG - 5ML = 12000 BOX | Bangladesh | India | NA | |||
38220090 | PHARMACEUTICAL >> USP-1097658-CEFIXIME 500 MG - PHARMACEUTICAL REFERENCE STANDARD - 1 NOS | United States | India | 0.00 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG - 1NOS ALL BELOW ITEMS ARE PHARMACEUTLCAL REFERENCE STANDARDS PRS ASST-DUTY UNDER PROTEST | France | India | 200 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - | United States | India | 1 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 3NOS - | United States | India | 1500 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - | United States | India | 1 | |||
30049099 | WZ >> SUPRAX CEFIXIME FOR ORAL SUSPENSION USP , 200 MG-5ML IMP.TL - .NO.TL-WZ-2413-2016-2361 DT:13-04-2016 | United States | India | 15 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 3 | |||
30041090 | PRICE >> CEFIXIME TRIHYDRATE POWDER FOR ORAL SUSPENSION 100-5 , MG-ML - OROKEN CHILDREN QTY: 20 NOS , PRICE: EUR 4.44 EACH | France | India | 0.10 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29339900 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 1 | |||
30049099 | SUSPENSION >> SUPRAX-CEFIXIME POWDER , FOR SUSPENSION LOT-1 200 MG IN 5 ML 50 ML IN 1 BOTTLE FOR R & D UNIT ONLY | United States | India | 17 | |||
30043200 | CEFIXIME >> SUPRAX CEFIXIME SUPRAX CEFIXIME 200 MG-5ML P-NO.:27437-0206-03 | United States | India | 3 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME QTY:2 X 500 MG , VALUE:USD 265-EACH FOC | Italy | India | 0.01 | |||
38229010 | 1097658 CEFIXIME 500 MG CERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
30049099 | OROKEN ENFANTS 100 MG/5 ML CEFIXIME 22 BOXES OF 1 BOTTLE NCV | Austria | India | 22 | |||
38229010 | 1097658 - CEFIXIME 500 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1097658 - CEFIXIME 500 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
30049099 | CEFTID 200 MG CAPSULE (CEFIXIME) ETC (DA-6-1-94-19246) | Bangladesh | India | NA | |||
30049099 | CEFIXIME TABLETS 200 MG | Malta | India | 40 | |||
30049099 | CEFIXIME 200 MG FILM COATED TABLETS 7 BOXES X 14 TABLETS = 98 TABLETS NCV | Austria | India | 7 | |||
30049099 | CEFIXIME 400 MG FILM COATED TABLETS 7 BOX X 14 TABLETS = 98 TABLETS NCV | Italy | India | 7 | |||
29419090 | CEFIXIME 500 MG PC NO.SBPL/013/2022-23 DT.15.12.2022 DETAILS AS PER DOCUMENT | United States | India | 0.01 | |||
30049099 | CEFIXIME FOR ORAL SUSPENSION 200 MG / 5 ML - 15 BOTTLES FOR R & D PURPOSE ONLY | United States | India | 15 | |||
30049099 | CEFIXIME FOR ORAL SUSPENSION 200 MG / 5 ML - 15 BOTTLES FOR R & D PURPOSE ONLY | United States | India | 15 | |||
30049099 | PHARMACEUTICAL >> PHARMACEUTICAL FINISHED PHARMACEUTICAL FINISHED PRODUCTS: CEFIXIME CAPSULE 200 MG HS Code : 30049099 | Bangladesh | India | 199800 | |||
30049099 | TABLETS >> TABLETS OROKEN Cefixime Trihydrate 200 mg Tablets OROKEN 200mg Film-CoatedTablets Licence Number: TL-WZ-20-004610 19 PACK X 8 TABLE 30049099 HS Code | France | India | 19 | |||
30049099 | TABLETS >> CEFIXIME TABLETS CEFIXIME TABLETS 200 MILLIGRAM MG SUPRAX [301 TABS] [C.O.UK] [FOR R & D TESTING PURPOSE , NOT FOR COMMERCIAL USE] | United Kingdom | India | 43 | |||
30049087 | WZ >> CEFIXIME CAPSULES STRENGTH 400 MG 14 BOTTELS 1 BOTTLE X 50CAPSULES FOR R & D PURPOSE TEST LICENCE - TL-WZ-19-002 | United States | India | 1.97 | |||
29331999 | CEFIXIME >> CEFIXIME 500 MG FOR LABORATORY PURPOSE ONLY | United States | India | 1 | |||
30049099 | TABLETS >> CEFIXIME TABLETS OROKEN CEFIXIME TABLETS 200 MG FOR R & D PURPOSE PACK SIZE 8's | Germany | India | 63 | |||
30049099 | SUSPENSION >> ORAL SUSPENSION OROKEN CEFIXIME INFAFANT POWDER FOR ORAL SUSPENSION 40 MG -5ML FOR R & D PURPOSE PACK SIZE 40 ML | Germany | India | 30 | |||
30049099 | TABLETS >> CEFIXIME TABLETS OROKEN CEFIXIME TABLETS 200 MG FOR R & D PURPOSE PACK SIZE 8's | Germany | India | 7 | |||
38220090 | VIAL >> PHARMACEIUTICAL REFERENCE STANDARD -C0684000 CEFIXIME CRS 1VIAL S PER SALES UNIT 200 MG PER VIAL QTY 1 PCS . | France | India | 0.01 | |||
30049099 | TABLETS >> CEFIXIME GRANULES 50 MG-QTY-396 TABLETS-FOR TEST OR ANALYSIS PURPOSE ONLY- PERISHABLE CARGO | China | India | 0.10 | |||
30049087 | CEFIXIME >> CEFIXIME ORAL CEFIXIME ORAL SUSPENSION 200 MG-5ML SUPRAX R FOR R &D PURPOSE ONLY | United States | India | 24 | |||
38220090 | CEFIXIME >> REFERENCE STANDARD CEFIXIME 500 MG -125110-14-7 N | Spain | India | 1 | |||
30041090 | PRICE >> CEFIXIME GRANULES FOR ORAL SUSPENSION 100-5 MG-ML SUPRAX QTY: 15NOS PRICE: EUR 12.75 EACH | Italy | India | 0.10 | |||
30049087 | CEFIXIME >> SUPRAX CAPSULE 400 MG CEFIXIME FOR R & D PURPOSE - | United States | India | 30 | |||
30041090 | PRICE >> CEFIXIME GRANULES FOR ORAL SUSPENSION 100-5 MG-ML SUPRAX QTY: 15NOS PRICE: EUR 20.26 EACH | Italy | India | 0.10 | |||
38220090 | PHARMACEUTICAL >> CEFIXIME 500 MG -125110-14-7N REF:1097658 PHARMACEUTICAL - REFERENCE STANDARDS - FOR LABARATORY USE ONLY | United States | India | 2 | |||
30041090 | PRICE >> CEFIXIME GRANULES FOR ORAL SUSPENSION 100-5 MG-ML SUPRAX QTY: 30NOS PRICE: CAD 28.46 EACH | Canada | India | 0.10 | |||
29419090 | PHARMACEUTICAL >> CEFIXIME 500 MG 500 MG X 52 NOS = 26000 MG = 0.026 KGS NOT FOR FOOD INDUSTRY - ONLY FOR PHARMACEUTICAL INDUSTRY | United States | India | 52 | |||
30049099 | SUSPENSION >> CEFIXIME SUSPENSION BOX WITH BOTTLE WITH POWDER FOR 100 ML CEFIXIME SUSPENSION - 100-5 MG-ML DENVAR FOR R & D USE ONLY | Mexico | India | 12 | |||
30049099 | CAPSULES >> CAPSULES DENVAR BOX WITH 6 CAPSULES DENVAR 6 CAPSULES-PACK CEFIXIME CAPSUL - ES 400 MG FOR R & D USE ONLY | Mexico | India | 30 | |||
38220090 | VIAL >> PHARMACEIUTICAL REFERENCE STANDARD -C0684000 CEFIXIME CRS 1VIAL S PER SALES UNIT 200 MG PER VIAL | France | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 5 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
30042019 | TABLETS >> TABLETS SUPRRAX CEFIXIME 200 MG TABLETS SUPRRAX 200 MG TABLETS FOR R & DTEST LIC. NO. TL-WZ-18-001582 DT. 19.03.2018 1 X 10 PACK X | Hungary | India | 150 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
30049099 | TABLETS >> CEFIXIME TABLETS CEFIXIME TABLETS 400 MG BRAND-SUPRAX PACK SIZE 10 TAB-BLISTER TEST LICENSE NO.TL-NZ-18-000038 DT:09-01-2018 | Canada | India | 150 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 4 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
38220090 | REAGENT >> C-919 CEFIXIME IMPURITY E 50 MG[LAB REAGENT FOR RUO] - | Canada | India | 1 | |||
38220090 | CEFIXIME >> CEFIXIME 500 MG | United States | India | 1 | |||
29335990 | PHARMACEUTICAL >> USP-1097658-CEFIXIME 500 MG PHARMACEUTICAL REFERENCE STANDARD - 1NOS | United States | India | 500 | |||
30049099 | SUSPENSION >> ORAL SUSPENSION RE-IMPORT PHARMACEUTICAL ITEMS - 102 CTN OF CESH-100 CEFIXIM FOR ORAL SUSPENSION USP 100 MG- 5 ML | India | India | 10175 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | 60 More Columns Available | ||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME 500 MG - 1NOS | United States | India | 500 | |||
29339900 | LABARATORY >> CEFIXIME 500 MG -125110-14-7 REFRENCE : 1097658 REFERENCE STANDARD MATERIAL-FOR LABARATORY USE ONLY | United States | India | 1 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS - | United States | India | 500 | |||
38220090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - USP REFERENCE STANDARDS - FOR LABORATORY USE | United States | India | 1 | |||
30041090 | PRICE >> CEFIXIME TRIHYDRATE POWDER FOR ORAL SUSPENSION 100-5 MG-ML OROKEN CHILDREN QTY: 10 NOS , PRICE: USD 25 EACH | France | India | 0.30 | |||
30043200 | CEFIXIME >> SUPRAX CEFIXIME SUPRAX CEFIXIME 200 MG-5ML P-NO.:27437-0206-02 | United States | India | 3 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> CEFIXIME 500 MG | United States | India | 500 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 2 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
30049099 | TABLETS >> CEFIXIME FINE GRANULES 50 MG CEFSPAN -QTY-480 TABLETS-FOR TEST OR ANALYSIS PURPOSE ONLY- PERISHABLE CARGO | China | India | 0.10 | |||
30049099 | TABLETS >> CEFIXIME TABLETS CEFIXIME TABLETS 400 MG SUPRAX PACK -10 S , QTY-20 BLISTER AS PER TEST LIC.NO.TL-BDZ-21-000223 DT:22-09-2021 | Canada | India | 200 | |||
29419090 | PRICE >> CEFIXIME QTY:1 X 500 MG , PRICE:USD-245.00 FOC HS 29419090 | China | India | 0.01 | |||
30049099 | AURO-CEFIXIME TABLETS, 400 MG 400 MG 7 BLISTER 7'S BLISTER LOT# OXMTS21019A | Canada | India | 7 | |||
30049099 | CEFIXIME POWDER FOR ORAL SUSPENSION 100 MG / 5 ML, 12 BOXES OF 1 BOTTLE NCV | Austria | India | 12 | |||
30049099 | FREE SAMPLE - CEFIXIME ORAL SUSPENSION 100 MG/5ML OROKEN 100MG/5ML 100/5 MG/ML - NO COMMERCIAL VALUE | Senegal | India | 50 | |||
30039099 | CEFIXIME 100 MG - 5ML = 12000 BOX | Bangladesh | India | NA | |||
38220090 | PHARMACEUTICAL >> USP-1097658-CEFIXIME 500 MG - PHARMACEUTICAL REFERENCE STANDARD - 1 NOS | United States | India | 0.00 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG - 1NOS ALL BELOW ITEMS ARE PHARMACEUTLCAL REFERENCE STANDARDS PRS ASST-DUTY UNDER PROTEST | France | India | 200 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 1NOS | United States | India | 500 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - | United States | India | 1 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - 3NOS - | United States | India | 1500 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG - | United States | India | 1 | |||
30049099 | WZ >> SUPRAX CEFIXIME FOR ORAL SUSPENSION USP , 200 MG-5ML IMP.TL - .NO.TL-WZ-2413-2016-2361 DT:13-04-2016 | United States | India | 15 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 3 | |||
30041090 | PRICE >> CEFIXIME TRIHYDRATE POWDER FOR ORAL SUSPENSION 100-5 , MG-ML - OROKEN CHILDREN QTY: 20 NOS , PRICE: EUR 4.44 EACH | France | India | 0.10 | |||
29339900 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29309099 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29339900 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 1 | |||
30049099 | SUSPENSION >> SUPRAX-CEFIXIME POWDER , FOR SUSPENSION LOT-1 200 MG IN 5 ML 50 ML IN 1 BOTTLE FOR R & D UNIT ONLY | United States | India | 17 | |||
30043200 | CEFIXIME >> SUPRAX CEFIXIME SUPRAX CEFIXIME 200 MG-5ML P-NO.:27437-0206-03 | United States | India | 3 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME QTY:2 X 500 MG , VALUE:USD 265-EACH FOC | Italy | India | 0.01 | |||
38229010 | 1097658 CEFIXIME 500 MG CERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
30049099 | OROKEN ENFANTS 100 MG/5 ML CEFIXIME 22 BOXES OF 1 BOTTLE NCV | Austria | India | 22 | |||
38229010 | 1097658 - CEFIXIME 500 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1097658 - CEFIXIME 500 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
30049099 | CEFTID 200 MG CAPSULE (CEFIXIME) ETC (DA-6-1-94-19246) | Bangladesh | India | NA | |||
30049099 | CEFIXIME TABLETS 200 MG | Malta | India | 40 | |||
30049099 | CEFIXIME 200 MG FILM COATED TABLETS 7 BOXES X 14 TABLETS = 98 TABLETS NCV | Austria | India | 7 | |||
30049099 | CEFIXIME 400 MG FILM COATED TABLETS 7 BOX X 14 TABLETS = 98 TABLETS NCV | Italy | India | 7 | |||
29419090 | CEFIXIME 500 MG PC NO.SBPL/013/2022-23 DT.15.12.2022 DETAILS AS PER DOCUMENT | United States | India | 0.01 | |||
30049099 | CEFIXIME FOR ORAL SUSPENSION 200 MG / 5 ML - 15 BOTTLES FOR R & D PURPOSE ONLY | United States | India | 15 | |||
30049099 | CEFIXIME FOR ORAL SUSPENSION 200 MG / 5 ML - 15 BOTTLES FOR R & D PURPOSE ONLY | United States | India | 15 | |||
30049099 | PHARMACEUTICAL >> PHARMACEUTICAL FINISHED PHARMACEUTICAL FINISHED PRODUCTS: CEFIXIME CAPSULE 200 MG HS Code : 30049099 | Bangladesh | India | 199800 | |||
30049099 | TABLETS >> TABLETS OROKEN Cefixime Trihydrate 200 mg Tablets OROKEN 200mg Film-CoatedTablets Licence Number: TL-WZ-20-004610 19 PACK X 8 TABLE 30049099 HS Code | France | India | 19 | |||
30049099 | TABLETS >> CEFIXIME TABLETS CEFIXIME TABLETS 200 MILLIGRAM MG SUPRAX [301 TABS] [C.O.UK] [FOR R & D TESTING PURPOSE , NOT FOR COMMERCIAL USE] | United Kingdom | India | 43 | |||
30049087 | WZ >> CEFIXIME CAPSULES STRENGTH 400 MG 14 BOTTELS 1 BOTTLE X 50CAPSULES FOR R & D PURPOSE TEST LICENCE - TL-WZ-19-002 | United States | India | 1.97 | |||
29331999 | CEFIXIME >> CEFIXIME 500 MG FOR LABORATORY PURPOSE ONLY | United States | India | 1 | |||
30049099 | TABLETS >> CEFIXIME TABLETS OROKEN CEFIXIME TABLETS 200 MG FOR R & D PURPOSE PACK SIZE 8's | Germany | India | 63 | |||
30049099 | SUSPENSION >> ORAL SUSPENSION OROKEN CEFIXIME INFAFANT POWDER FOR ORAL SUSPENSION 40 MG -5ML FOR R & D PURPOSE PACK SIZE 40 ML | Germany | India | 30 | |||
30049099 | TABLETS >> CEFIXIME TABLETS OROKEN CEFIXIME TABLETS 200 MG FOR R & D PURPOSE PACK SIZE 8's | Germany | India | 7 | |||
38220090 | VIAL >> PHARMACEIUTICAL REFERENCE STANDARD -C0684000 CEFIXIME CRS 1VIAL S PER SALES UNIT 200 MG PER VIAL QTY 1 PCS . | France | India | 0.01 | |||
30049099 | TABLETS >> CEFIXIME GRANULES 50 MG-QTY-396 TABLETS-FOR TEST OR ANALYSIS PURPOSE ONLY- PERISHABLE CARGO | China | India | 0.10 | |||
30049087 | CEFIXIME >> CEFIXIME ORAL CEFIXIME ORAL SUSPENSION 200 MG-5ML SUPRAX R FOR R &D PURPOSE ONLY | United States | India | 24 | |||
38220090 | CEFIXIME >> REFERENCE STANDARD CEFIXIME 500 MG -125110-14-7 N | Spain | India | 1 | |||
30041090 | PRICE >> CEFIXIME GRANULES FOR ORAL SUSPENSION 100-5 MG-ML SUPRAX QTY: 15NOS PRICE: EUR 12.75 EACH | Italy | India | 0.10 | |||
30049087 | CEFIXIME >> SUPRAX CAPSULE 400 MG CEFIXIME FOR R & D PURPOSE - | United States | India | 30 | |||
30041090 | PRICE >> CEFIXIME GRANULES FOR ORAL SUSPENSION 100-5 MG-ML SUPRAX QTY: 15NOS PRICE: EUR 20.26 EACH | Italy | India | 0.10 | |||
38220090 | PHARMACEUTICAL >> CEFIXIME 500 MG -125110-14-7N REF:1097658 PHARMACEUTICAL - REFERENCE STANDARDS - FOR LABARATORY USE ONLY | United States | India | 2 | |||
30041090 | PRICE >> CEFIXIME GRANULES FOR ORAL SUSPENSION 100-5 MG-ML SUPRAX QTY: 30NOS PRICE: CAD 28.46 EACH | Canada | India | 0.10 | |||
29419090 | PHARMACEUTICAL >> CEFIXIME 500 MG 500 MG X 52 NOS = 26000 MG = 0.026 KGS NOT FOR FOOD INDUSTRY - ONLY FOR PHARMACEUTICAL INDUSTRY | United States | India | 52 | |||
30049099 | SUSPENSION >> CEFIXIME SUSPENSION BOX WITH BOTTLE WITH POWDER FOR 100 ML CEFIXIME SUSPENSION - 100-5 MG-ML DENVAR FOR R & D USE ONLY | Mexico | India | 12 | |||
30049099 | CAPSULES >> CAPSULES DENVAR BOX WITH 6 CAPSULES DENVAR 6 CAPSULES-PACK CEFIXIME CAPSUL - ES 400 MG FOR R & D USE ONLY | Mexico | India | 30 | |||
38220090 | VIAL >> PHARMACEIUTICAL REFERENCE STANDARD -C0684000 CEFIXIME CRS 1VIAL S PER SALES UNIT 200 MG PER VIAL | France | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 5 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
30042019 | TABLETS >> TABLETS SUPRRAX CEFIXIME 200 MG TABLETS SUPRRAX 200 MG TABLETS FOR R & DTEST LIC. NO. TL-WZ-18-001582 DT. 19.03.2018 1 X 10 PACK X | Hungary | India | 150 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
30049099 | TABLETS >> CEFIXIME TABLETS CEFIXIME TABLETS 400 MG BRAND-SUPRAX PACK SIZE 10 TAB-BLISTER TEST LICENSE NO.TL-NZ-18-000038 DT:09-01-2018 | Canada | India | 150 | |||
29419090 | CEFIXIME >> USP-1097658_CEFIXIME - 500 MG | United States | India | 1 | |||
29419090 | CEFIXIME >> EP-C0684000_CEFIXIME 200 MG | France | India | 4 |
Volza's data of India Cefixime mg imports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of India Cefixime mg imports helps you create a import strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find India Cefixime mg import market intelligence of last 10 years with buyer, supplier, price and volume from Volza.com
You can find New markets for Cefixime mg imports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Top 5 HSN codes for Cefixime mg are HSN Code 29419090 , HSN Code 30049099, HSN Code 29339900, HSN Code 29309099, HSN Code 38220090, You can check for details at https://www.volza.com/hs-codes.
Volza's data of India Cefixime mg imports is 100% authentic as it is based on actual import export shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of India Cefixime mg imports contains strategic information and is very useful for importers and exporters who want to expand global trade, improve supply chain of Cefixime mg, find economical vendors, new buyers and fast growing markets.
Data of India Cefixime mg imports contains date of shipment, Name and contact details of importer, exporter, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of India Cefixime mg imports every month.
As per the Volza's India import data of Cefixime mg, United States accounted for maximum share with 125 shipments followed by France with 14 and Canada at 3rd spot with 14 shipments.
You can download latest data of March-2024 of India Cefixime mg imports here
You can download Volza India Cefixime mg import data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners